NCT05945797 is a NA clinical trial of Dexamethasone 4mg in Common Bile Duct Diseases, sponsored by Gujranwala medical college District Headquarters Hospital, Gujranwala.

Who is sponsoring NCT05945797?

NCT05945797 is sponsored by Gujranwala medical college District Headquarters Hospital, Gujranwala.

What drugs are being tested in NCT05945797?

Interventions in NCT05945797: Dexamethasone 4mg.

What condition does NCT05945797 study?

NCT05945797 studies Common Bile Duct Diseases, Common Bile Duct Calculi, Common Bile Duct Stricture, Common Bile Duct Neoplasms, Common Bile Duct Dilatation.

Is NCT05945797 still recruiting?

NCT05945797 is currently completed. Last updated 21 March 2025.

Last reviewed 2025-03-21 · How we verify

NCT05945797

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Dexamethasone on Common Bile Duct Cannulation Time

Completed NA Last updated 21 March 2025

What this trial tests

NA trial testing Dexamethasone 4mg in Common Bile Duct Diseases in 80 participants. Completed in 16 May 2024.

Timeline

1 August 2023

Primary endpoint
12 April 2024

16 May 2024

Quick facts

Lead sponsor	Gujranwala medical college District Headquarters Hospital, Gujranwala
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	80
Start date	1 August 2023
Primary completion	12 April 2024
Estimated completion	16 May 2024
Sites	1 location across Pakistan

Drugs / interventions tested

Dexamethasone 4mg — full drug profile →

Conditions studied

Common Bile Duct Diseases — all drugs for Common Bile Duct Diseases →
Common Bile Duct Calculi — all drugs for Common Bile Duct Calculi →
Common Bile Duct Stricture — all drugs for Common Bile Duct Stricture →
Common Bile Duct Neoplasms — all drugs for Common Bile Duct Neoplasms →

Sponsor

Gujranwala medical college District Headquarters Hospital, Gujranwala

Who can join

18 and older, any sex, with Common Bile Duct Diseases or Common Bile Duct Calculi. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of this clinical trial is to evaluate the effects of dexamethasone on common bile duct cannulation time during endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary pathologies. The study will also study the effects of dexamethasone on total procedure time and total fluoroscopy time during ERCP. Participants will be divided into two groups, treatment group and placebo group. Patients in treatment group will receive dexamethasone and those in placebo group will be given normal saline before undergoing ERCP. The results in both groups will be compared to determine the effects of dexamethasone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexamethasone 4mg

Trials testing the same drug.

NCT07330999 — Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults · NA · recruiting
NCT07216820 — Interscalene vs Phrenic-sparing Blocks in Obesity and Effect of Maximum Inspiratory Pressure · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting
NCT07180953 — Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty · Phase 4 · recruiting
NCT07180940 — Comparison of Perineural Dexamethasone Versus Dexmedetomidine as Adjuvants to Erector Spinae Plane Block in Lumbar Spine · Phase 4 · recruiting

Other Gujranwala medical college District Headquarters Hospital, Gujranwala trials

Trials by the same sponsor.

NCT07352215 — PRP Plus Fractional CO₂ Laser for Acne Scars · NA · recruiting
NCT07327983 — Azelaic Acid 20% vs Hydroquinone 4% in Epidermal Melasma · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05945797 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gujranwala medical college District Headquarters Hospital, Gujranwala
Last refreshed: 21 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05945797.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing